ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00562783
Recruitment Status : Completed
First Posted : November 22, 2007
Last Update Posted : October 23, 2013
Sponsor:
Collaborator:
Vigconic (International) Ltd.
Information provided by:
Hospital Authority, Hong Kong

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2006